Zydus Wellness Announces Audited Financial Results for Q4 FY26 and Recommends Dividend
Zydus Wellness Limited announced the outcome of its Board of Directors meeting held on May 18, 2026, wherein the Board approved the audited financial results for the quarter and financial year ended on March 31, 2026. The Board also recommended a Final Dividend.The Board of Directors recommended a Final Dividend of ₹ 1.20 per equity share, based on a face value of ₹ 2 per share. This dividend is subject to the approval of the shareholders at the ensuing Annual General Meeting scheduled for Tuesday, August 4, 2026.
Financial Performance Overview
The Company reported audited financial results for the quarter and financial year ended March 31, 2026, which were reviewed by the Audit Committee and taken on record by the Board. The financial results were prepared in accordance with Indian Accounting Standards (Ind AS).The financial results confirm the following key metrics for the quarter and full year:
Standalone Financial Results (in Million)
| Particulars | Quarter Ended March 31, 2026 | Year Ended March 31, 2026 |
|---|---|---|
| Total Income | 1,374 | 5,940 |
| Total Expenses | 1,222 | 5,340 |
| Net Profit | 133 | 376 |
| Total Comprehensive Income | 134 | 373 |
Consolidated Financial Results (in Million)
| Particulars | Quarter Ended March 31, 2026 | Year Ended March 31, 2026 |
|---|---|---|
| Total Income | 14,859 | 39,674 |
| Total Expenses | 13,086 | 36,961 |
| Net Profit | 1,620 | 1,972 |
| Total Comprehensive Income | 1,598 | 1,926 |
Corporate Highlights and Accounting Adjustments
The Company confirmed that its operations are confined to one segment: "Consumer Products."During the period, Zydus Wellness also noted significant corporate activities impacting its finances:
- Acquisitions: The consolidated financial results include the operations of NIPL (Naturell (India) Private Limited), which was voluntarily liquidated and its business undertaking was distributed on a going concern basis to the Company effective from September 20, 2025. Additionally, the Group consolidated the operations of Comfort Click Limited (CCL), which was acquired on August 29, 2025.
- One-Time Charges: The financial statements include specific one-time impacts:
* One time impact of the New Labour Codes amounted to ₹ 15 Million in the quarter ended March 31, 2026, and ₹ 66 Million for the full year.
Financial Position Summary (March 31, 2026)
The audited balance sheet details provided the following financial standing:Standalone Statement of Assets and Liabilities (in Million)
| Particulars | As at March 31, 2026 |
|---|---|
| Total Non-Current Assets | 41,625 |
| Total Current Assets | 1,108 |
| Total Assets | 42,733 |
| Total Equity | 40,326 |
| Total Non-Current Liabilities | 1,377 |
| Total Current Liabilities | 1,030 |
| Total Equity and Liabilities | 42,733 |
Consolidated Statement of Assets and Liabilities (in Million)
| Particulars | As at March 31, 2026 |
|---|---|
| Total Non-Current Assets | 89,411 |
| Total Current Assets | 13,667 |
| Total Assets | 103,078 |
| Total Equity | 58,260 |
| Total Non-Current Liabilities | 37,533 |
| Total Current Liabilities | 17,285 |
| Total Equity and Liabilities | 103,078 |
Cash Flow Summary
The cash flow analysis showed substantial operational and financing activities for the year.Standalone Cash Flow from Operating Activities (in Million)
The net cash from operating activities was ₹ 352 Million, up from ₹ 400 Million the previous year.
Consolidated Cash Flow from Operating Activities (in Million)
The Group generated a net cash from operating activities of ₹ 2,264 Million, compared to ₹ 3,800 Million in the previous period.
The Board meeting commenced at 11:15 a.m. and concluded at 12:45 p.m. The summary of the audited financial results was available for review during the meeting.
ZYDUSWELL Stock Price Movement
As of 1:11 PM, Zydus Wellness Limited shares are slipping by 1.28% in live trading, trading at ₹495.7. The stock is currently seeing heavy activity with a volume of 522,148 shares, yet remains notably above its intraday low of ₹484.95.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.